Tecentriq (atezolizumab)

pCPA File Number: 21056
Negotiation Status:
Concluded with an LOI
Indication(s):
Non-small Cell Lung Cancer
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
PC0115-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: